S
Stockadora

Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 4604 Reports
🤖 AI Analyzed
Recent
📄 Page 4 of 384
NewHydrogen, Inc.
10-K March 30, 2026

Key Highlights

  • Developing ThermoLoop™ technology to produce green hydrogen using heat instead o...
  • Targeting a production cost of under $1.00 per kilogram for green hydrogen.
  • Business model focused on licensing technology to large manufacturers to minimiz...
Read Analysis
🤖 AI Generated
CareView Communications Inc
10-K March 30, 2026

Key Highlights

  • Transitioned to a sales-based model, driving a 232% increase in sales-based cont...
  • Achieved positive cash flow from operations of $805,000 in 2025.
  • Secured strategic pre-approval agreements with major hospital networks like Heal...
Read Analysis
🤖 AI Generated
Domtar CORP
10-K March 30, 2026

Key Highlights

  • Strategic shift toward high-margin specialty products and recycled packaging to ...
  • Aggressive debt reduction strategy, raising over $200 million through non-core a...
  • High operational self-sufficiency, generating 75% of power from wood by-product ...
Read Analysis
🤖 AI Generated
Scienture Holdings, Inc.
10-K March 30, 2026

Key Highlights

  • Successful FDA approval and launch of SCN-102 in 2025.
  • Strategic pivot to a pure-play drug development model after exiting food tech.
  • Three additional drug candidates in the pipeline with market entry targeted for ...
Read Analysis
🤖 AI Generated
Actinium Pharmaceuticals, Inc.
10-K March 30, 2026

Key Highlights

  • Lead candidate Iomab-B addresses a significant market gap in bone marrow transpl...
  • ATNM-400 shows potential to outperform current cancer treatments by 3–5 times in...
  • The company is strategically positioning itself as an acquisition target for maj...
Read Analysis
🤖 AI Generated
DiaMedica Therapeutics Inc.
10-K March 30, 2026

Key Highlights

  • Advancing DM199, a synthetic KLK1 protein, for stroke, preeclampsia, and fetal g...
  • Positive clinical results from a preeclampsia study in South Africa showing safe...
  • Adaptive design for the ReMEDy2 stroke trial allows for early stopping to preser...
Read Analysis
🤖 AI Generated
Fifth Third Holdings Funding, LLC
10-K March 30, 2026

Key Highlights

  • Issued $1.2 billion in asset-backed securities in 2023.
  • Maintained a low net loss rate of less than 0.85% on the loan portfolio.
  • Strong credit enhancement through a $6.2 million reserve account and overcollate...
Read Analysis
🤖 AI Generated
LINGERIE FIGHTING CHAMPIONSHIPS, INC.
10-K March 30, 2026

Key Highlights

  • Strong digital footprint with over 800,000 YouTube subscribers and 250 million v...
  • Lean production model utilizes contractors to keep operational costs low.
  • Diversified revenue streams including international licensing, merchandise, and ...
Read Analysis
🤖 AI Generated
Kraig Biocraft Laboratories, Inc.
10-K March 30, 2026

Key Highlights

  • Pioneering genetic engineering to produce high-performance hybrid spider silk.
  • Strategic shift toward commercial production in Vietnam using a low-cost 'plug a...
  • Strong intellectual property portfolio including over 10 patents and proprietary...
Read Analysis
🤖 AI Generated
Osisko Development Corp.
40-F March 30, 2026

Key Highlights

  • Flagship Cariboo Gold Project development is the primary growth driver.
  • Secured a $100 million credit line to fund operations through 2026.
  • Streamlined portfolio by selling the San Antonio Gold Project for $30 million.
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage